Artsci

Nogan LLC is a registered 501(c)(3) nonprofit organization based in Los Angeles, CA. They are the Terasaki Institute for Biomedical Innovation, dedicated to advancing personalized healthcare through cutting-edge research and innovation in various fields, including personalized nutrition, physiological models, implants, devices, cells, and biomaterials. Led by founder Dr. Paul I. Terasaki, Nogan LLC brings together a team of renowned scientists and researchers, collaborating with affiliate faculty, alumni, and current interns to drive impactful advancements in the field of bioengineering. With a strong focus on innovation and impact, Nogan LLC hosts the Terasaki Innovation Summit, an annual event that brings together leaders and experts in the field to discuss and explore the latest advancements and challenges in personalized healthcare. Through their research platforms and laboratories, such as the Xiling Shen Laboratory and the Alireza Hassani Laboratory, Nogan LLC aims to bridge the gap between scientific discovery and practical applications, ultimately improving patient outcomes and revolutionizing the healthcare industry.Generated from the website

Pharm Bio Inc, based in Los Angeles, CA, specializes in pharmaceutical bioinformatics, a cutting-edge discipline emerging from the genomics revolution. This field is essential to biomedicine, with applications spanning pharmacy, medicine, biology, and medicinal chemistry, leveraging high-throughput methods for gene sequencing and data analysis. The company offers courses tailored for individuals in the life sciences, particularly those interested in how informatics tools can decode complex cellular processes and contribute to drug development. With a focus on harnessing vast amounts of new data, Pharm Bio Inc aims to equip learners with the knowledge needed to explore the frontiers of medicinal chemistry. Generated from the website

Calneuro Research Group Inc, located in Los Angeles, CA, specializes in clinical trials focusing on neurological conditions such as Alzheimer's Disease, Depression, and Obsessive-Compulsive Disorder (OCD). The organization is dedicated to advancing research and treatment options through patient-centered studies and innovative methodologies. Committed to enhancing the understanding of neuropsychiatric disorders, Calneuro Research Group actively engages with potential participants and provides comprehensive information regarding upcoming studies. Their mission includes fostering communication and collaboration within the medical community to improve patient outcomes. Generated from the website